a class of this embodiment the crystalline form of the present invention is present in about 5 to about 100 by weight of the drug substance in a second class of this embodiment the crystalline form of the present invention is present in about 10 to about 100 by weight of the drug substance in a third class of this embodiment the crystalline form of the present invention is present in about 25 to about 100 by weight of the drug substance in a fourth class of this embodiment the crystalline form of the present invention is present in about 50 to about 100 by weight of the drug substance in a fifth class of this embodiment the crystalline form of the present invention is present in about 75 to about 100 by weight of the drug substance in a sixth class of this embodiment substantially all of the drug substance is the crystalline form of the present invention i e the drug substance is substantially phase pure crystalline in another class of this embodiment at least 5 by weight of the drug substance is the crystalline form of the present invention in a yet another class of this embodiment at least 10 by weight of the drug substance is the crystalline form of the present invention in a still another class of this embodiment at least 15 by weight of the drug substance is the crystalline form of the present invention in another class of this embodiment at least 20 by weight of the drug substance is the crystalline form of the present invention in yet another class of this embodiment at least 25 by.